A clinical risk score for the prediction of very late stent thrombosis in drug eluting stent patients

EuroIntervention

Volumn 6, Issue 8, 2011, Pages 949-954

  Baran, Kenneth W ^a   Lasala, John M ^b   Cox, David A ^c   Mascioli, Stephen R ^d   Song, Aijun ^d   Deshpande, Mahesh C ^d   Jacoski, Mary V ^d   Dawkins, Keith D ^d  

^a John Nasseff Heart Hospital   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LEHIGH VALLEY HOSPITAL   (United States)

^d BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

Drug eluting stent; Risk score; Very late stent thrombosis

Indexed keywords

ARTICLE; BRACHYTHERAPY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; PREDICTION; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SMOKING; STENT THROMBOSIS;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FOLLOW-UP STUDIES; HUMANS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE;

EID: 79954548123     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV6I8A165     Document Type: Article

References (26)

1. Camenzind E, Steg PG, Wijns W. A Cause for Concern. Circulation 2007;115:1440-1455.
2. Harjai KJ, Orshaw P, Boura J, Sporn D. Comparison of Long-Term Outcomes of Bare Metal or Drug-Eluting Stent Implantation in Standard Versus Off-Label Coronary Narrowings. Am J Cardiol 2009;103:1537-1545.
3. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice M-C, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB. Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents. N Engl J Med 2007;356:998-1008. (Pubitemid 46376800)
4. Windecker S, Meier B. Late Coronary Stent Thrombosis. Circulation 2007;116:1952-1965.
5. Baran KW, Lasala JM, Cox DA, Song A, Deshpande MC, JacoskiMV, Mascioli SR. A Clinical Risk Score for Prediction of Stent Thrombosis. Am J Cardiol 2008;102:541-545.
6. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, on behalf of the Academic Research Consortium. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions. Circulation 2007;115:2344-2351.
7. Lasala JM, Cox DA, Dobies D, Muhlestein JB, Katopodis JN, Revtyak G, Baim DS, for the ARRIVE 1 Participating Physicians. Usage patterns and 2-year outcomes with the TAXUS express stent: Results of the US ARRIVE 1 registry. Catheter Cardiovasc Interv 2008;72:433-445.
8. Lasala JM, Cox DA, Dobies D, Baran K, Bachinsky WB, Rogers EW, Breall JA, Lewis DH, Song A, Starzyk RM, Mascioli SR, Dawkins KD, BaimDS, for the ARRIVE Physicians. Drug-eluting Stent Thrombosis in Routine Clinical Practice: 2 Year Outcomes and Predictors from the TAXUS ARRIVE Registries. Circ Cardiovasc Interv 2009;2:285-293.
9. Hosmer, David and Stanley Lemeshow (1989, 2000). Applied Logistic Regression. 2nd ed., 2000. NY: Wiley & Sons. A much-cited treatment utilized in SPSS routines.
10. Capodanno D, Capranzano P, Bucalo R, Sanfilippo A, Ruperto C, Caggegi A, Ussia G, Galassi A, Tamburino C. A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score. Clin Res Cardiol 2009;98:240-248.
11. Win HK, Caldera AE, Maresh K, Lopez J, Rihal CS, Parikh MA, Granada JF, Marulkar S, Nassif D, Cohen DJ, Kleiman NS, for the EVENT Registry Investigators. Clinical Outcomes and Stent Thrombosis Following Off-Label Use of Drug-Eluting Stents. JAMA 2007;297:2001-2009.
12. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, Kramer JM, Harrington RA, Matchar DB, Kandzari DE, Peterson ED, Schulman KA, Califf RM. Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent Implantation. JAMA 2007;297:159-168.
13. Brar SS, Kim J, Brar SK, Zadegan R, Ree M, Liu ILA, Mansukhani P, Aharonian V, Hyett R, Shen AYJ. Long-Term Outcomes by Clopidogrel Duration and Stent Type in a Diabetic Population With De Novo Coronary Artery Lesions. J Am Coll Cardiol 2008;51:2220-2227. (Pubitemid 351754993)
14. Ong ATL, McFadden EP, Regar E, de Jaegere PPT, van Domburg RT, Serruys PW. Late Angiographic Stent Thrombosis (LAST) Events With Drug-Eluting Stents. J Am Coll Cardiol 2005;45:2088-2092.
15. Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, Cheong SS, Kim JJ, Park SW, Park SJ. Stent Thrombosis, Clinical Events, and Influence of Prolonged Clopidogrel Use After Placement of Drug-Eluting Stent: Data From an Observational Cohort Study of Drug-Eluting Versus Bare-Metal Stents. J Am Coll Cardiol Intv 2008;1:494-503.
16. Airoldi F, Colombo A, Morici N, Latib A, Cosgrave J, Buellesfeld L, Bonizzoni E, Carlino M, Gerckens U, Godino C, Melzi G, Michev I, Montorfano M, Sangiorgi GM, Qasim A, Chieffo A, Briguori C, Grube E. Incidence and Predictors of Drug-Eluting Stent Thrombosis During and After Discontinuation of Thienopyridine Treatment. Circulation 2007;116:745-754. (Pubitemid 47255992)
17. King SB, III, Smith SC, Jr, Hirshfeld JW, Jr, Jacobs AK, Morrison DA, Williams DO, WRITING COMMITTEE MEMBERS, Feldman TE, Kern MJ, O'Neill WW, Schaff HV, Whitlow PL, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation 2008;117:261-295.
18. Mauri L. Health and Human Services Town Hall Meeting - Hot Topic I: A Prospective Randomized Trial of Prolonged Dual Antiplatelet Therapy After Stent Implantation: Critical Issues. Core Study Design and Design Complexities. Presented at: Transcatheter Cardiovascular Therapeutics; October 15, 2008; Washington, DC.
19. Antman EM, Wiviott SD, Murphy SA, Voitk J, Hasin Y, Widimsky P, Chandna H, Macias W, McCabe CH, Braunwald E. Early and Late Benefits of Prasugrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) Analysis. J Am Coll Cardiol 2008;51:2028-2033. (Pubitemid 351689056)
20. Wiviott SD, Braunwald E, McCabe CH, Horvath I, Keltai M, Herrman JPR, Van de Werf F, Downey WE, Scirica BM, Murphy SA, Antman EM. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial. Lancet 2008;371:1353-1363.
21. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Jüni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007;369:667-678. (Pubitemid 46281313)
22. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of Drug-Eluting Stents in Humans: Delayed Healing and Late Thrombotic Risk. J Am Coll Cardiol 2006;48:193-202. (Pubitemid 43929240)
23. Luscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, Virmani R. Drug-Eluting Stent and Coronary Thrombosis: Biological Mechanisms and Clinical Implications. Circulation 2007;115:1051-1058.
24. Leon MB, Allocco DJ, Dawkins KD, Baim DS. Late Clinical Events After Drug Eluting Stents -The Interplay Between Stent-Related and Natural History-Driven Events. J Am Coll Cardiol Intv 2009;2:504-511.
25. Jaffe R, Strauss BH. Late and Very Late Thrombosis of Drug-Eluting Stents: Evolving Concepts and Perspectives. J Am Coll Cardiol 2007;50:119-127. (Pubitemid 47007738)
26. Park DW, Park SW, Park KH, Lee BK, Kim YH, Lee CW, Hong MK, Kim JJ, Park SJ. Frequency of and Risk Factors for Stent Thrombosis After Drug-Eluting Stent Implantation During Long-Term Follow-Up. Am J Cardiol 2006;98:352-356. (Pubitemid 44062443)